News
People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...
Copycats and false advertisements are also to blame for the increased threats. Stemming from social media testimonials all ...
A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...
1h
News-Medical.Net on MSNWhat happens to your weight after quitting GLP-1 anti-obesity drugs?Stopping anti-obesity medications leads to significant weight regain, starting as early as eight weeks and stabilizing by six ...
9h
HealthDay on MSNGLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia RiskGlucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related ...
23h
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonistsLandmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
The "try and fail" language is flawed when weight loss is used as the primary measure of success with lifestyle interventions ...
The comedy club owner has since dropped a whopping 4st and currently weighs 13st, however, she has been left in tears due to ...
Significant’ weight returned weeks after stopping drug, say researchers who advise patients to adjust expectations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results